International Clinical Trial: A prospective, single-center, single-arm, historically controlled study initiated by investigators to evaluate the safety and efficacy of subcutaneous injection of Vuxinqibaimab in the treatment of adult subjects with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF)

Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126449) titled 'A prospective, single-center, single-arm, historically controlled study initiated by investigators to evaluate the safety and efficacy of subcutaneous injection of Vuxinqibaimab in the treatment of adult subjects with acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF)' on June 9.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Shanghai Pulmonary Hospital

Condition: Acute exacerbation of idiopathic pulmonary fibrosis

Intervention: Experimental group:Subcutaneous injection of Firsekibart

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-...